Danset 4 Mg 3 Ampoules

Danset 4 Mg 3 Ampoules

Description:

Danset 4 mg ampoules are a prescription antiemetic medication containing ondansetron, a selective 5-HT3 receptor antagonist. It is used to prevent and treat nausea and vomiting associated with chemotherapy, radiotherapy, and postoperative recovery. Each pack contains 3 sterile injectable ampoules, typically 4 mg/2 ml, designed for intravenous (iv) or intramuscular (im) administration by healthcare professionals in hospital or clinical settings.

Indications:

• Prevention of acute nausea and vomiting induced by cytotoxic chemotherapy.
• Prevention of nausea and vomiting associated with radiotherapy.
• Treatment and prevention of postoperative nausea and vomiting (ponv).
• Management of severe nausea and vomiting when oral administration is not possible, as directed by a physician.

Active Ingredients / Key Components:

• Ondansetron – 4 mg per ampoule (commonly 4 mg/2 ml solution for injection).
• Other excipients: full list of inactive ingredients is not available in the provided information; please refer to the package leaflet for complete composition.

Dosage & Administration / How to Use:

• Danset 4 mg ampoules are for parenteral use only and must be administered by a doctor, nurse, or qualified healthcare professional.
• Chemotherapy-induced nausea and vomiting (adults): Typical initial dose is 8 mg given as a slow iv injection immediately before chemotherapy, followed by further doses or infusion as prescribed. Exact regimen depends on emetogenic potential of chemotherapy and physician’s protocol.
• Radiotherapy-induced nausea and vomiting: Dose and timing are determined by the treating physician according to radiotherapy schedule.
• Postoperative nausea and vomiting (adults): A single 4 mg dose given by slow iv injection at induction of anesthesia or at the end of surgery, as directed by the anesthetist.
• Pediatric and elderly patients: Dosing must be individually adjusted by the physician based on age, weight, clinical condition, and current guidelines.
• Administer only as a slow iv injection or diluted infusion as per prescribing information; do not self-inject.
• Do not exceed the total daily dose recommended by your doctor. Duration of treatment depends on the underlying condition and response.
• Always follow the exact dosing schedule and route of administration prescribed by your healthcare provider.

Clinical Benefits:

• Effectively prevents and controls nausea and vomiting associated with chemotherapy and radiotherapy.
• Reduces the incidence and severity of postoperative nausea and vomiting, improving postoperative comfort and recovery.
• Acts selectively on 5-HT3 receptors in the gut and brain, helping to block the vomiting reflex triggered by serotonin release.
• Supports better adherence to cancer treatment by minimizing distressing gastrointestinal side effects.

Warnings & Contraindications:

• Contraindicated in patients with known hypersensitivity to ondansetron or any component of the formulation, or to other selective 5-HT3 receptor antagonists.
• Use with caution in patients with a history of cardiac arrhythmias, prolonged qt interval, congestive heart failure, or those taking other medicines that prolong qt interval.
• Use with caution in patients with electrolyte imbalances (e.g. hypokalemia, hypomagnesemia); these should be corrected before administration.
• Caution in patients with severe hepatic impairment; dose adjustment may be required as ondansetron clearance is reduced.
• May mask progressive ileus or gastric distension; monitor postoperative patients carefully.
• Consult your doctor before use if pregnant or planning pregnancy. Use in pregnancy only if clearly needed and prescribed.
• Ondansetron is excreted in breast milk; breastfeeding women should consult their doctor before use and may be advised to avoid breastfeeding or discontinue the drug.
• Inform your doctor about all medicines you are taking, especially other serotonergic drugs, antiarrhythmics, antidepressants, antipsychotics, and tramadol.
• Not intended for self-medication; hospital or clinical supervision is required.
• Keep out of reach of children.

Side Effects:

• Common side effects: Headache, sensation of flushing or warmth, constipation, local injection site reactions, and transient liver enzyme elevations.
• Less common side effects: Dizziness, hypotension, hiccups, fatigue, or transient visual disturbances during rapid iv administration.
• Serious side effects (seek immediate medical attention): Signs of allergic reaction (rash, itching, swelling of face/lips/tongue, difficulty breathing), chest pain, severe dizziness or fainting, fast or irregular heartbeat, or symptoms of serotonin syndrome when combined with other serotonergic agents (agitation, confusion, sweating, tremor, muscle rigidity).
• If any side effects are severe, persistent, or concerning, inform your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Do not freeze. Keep ampoules in the original carton to protect from light. Keep container tightly closed and out of reach of children. Do not use after the expiry date printed on the pack. Do not use if the solution is discolored, cloudy, or contains particles.

Specifications:

• Product type: Prescription antiemetic medicine (ondansetron injection).
• Form: Sterile solution for injection in ampoules.
• Strength: 4 mg ondansetron per ampoule (commonly 4 mg/2 ml).
• Pack size: 3 ampoules per pack.
• Route of administration: Intravenous (iv) or intramuscular (im), as directed by a healthcare professional.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.